Form 4: Pfizer CEO Receives Stock Grant
Insider Transaction (Form 4)
Albert Bourla, Chairman & CEO and a Director of Pfizer Inc, received 24 shares of common stock on July 31, 2026.
Summary
- Grant/award: acquired 24 Phantom Stock Units SSP at $25.01 ($600) on July 31, 2026; holds 786,154 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Albert Bourla — Director, Officer (Chairman & CEO)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-31 | Grant/award | Phantom Stock Units SSP | 24 | $25 | $600 | 786,154 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-31 | Grant/award (24 shares) |
Keywords
insider transaction, Form 4, PFE, PFIZER INC, neutral, Albert Bourla
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.